The following studies are under development. Use the links in the box on the left for information on each of the studies under development by the PASA Consortium.
Study Type: Phase 1/2 double blinded, placebo-controlled, within-subjects crossover dose exploration design
Protocol:Effect of Sublingual formulation of Dexmedetomidine HCl (BXCL 501) on Ethanol in Healthy Humans and Heavy Drinkers
Participating Site: VA Connecticut Healthcare System
Study Type:Phase II Randomized Controlled Trial (RCT)
Protocol:An Aldehyde Dehydrogenase 2 Inhibitor for PTSD and AUD
Participating Site:Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC)
AS140026-A3a Dewleen Baker, M.D. and Victoria Risbrough, Ph.D.
Study Type: Phase II Clinical Proof of Concept Trial
Protocol: Efficacy and Safety Study of PT150 (formerly ORG 34517) in Veterans with Comorbid PTSD and AUD
Participating Site: VA San Diego Health Care System (VASDHS)